Direct inhibition of thrombin may offer similar anticoagulant properties but also impact the underlying disease process. As we continue to gain experience and develop new DTIs, a new balance may ...
The "Hemostatic Wound Dressing Market by Type, by Application, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering.The global hemostatic wound dressing market ...
Novo Nordisk’s bispecific antibody Mim8 prevented bleeding events and caused no adverse safety events in the Phase III ...
Recothrom Market Report 2025 - Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 The Business Research Company ...
If walking is becoming difficult and physio isn’t working, cutting-edge treatments could be the next step. But which ones are ...
Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Blood ...
Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed ...
The global prothrombin complex concentrates market is on a strong upward trajectory, with projections indicating substantial growth in the coming decade. According to a recent report by Future Market ...
The data showed that Mim8 was well-tolerated and efficacious in children with haemophilia A with and without inhibitors. In part one of the FRONTIER3 study, participants with haemophilia A received ...
The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three for oncology, a weekly insulin, and innovations in obesity, hemophilia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback